Want to see RTO full AI Analyst Report?
Top Page
Rentokil Initial
(NYSE:RTO)
Select Model
Select Model
Rating:60Neutral
Price Target:
$30.00
▼(-8.42% Downside)
Action:Reiterated
Date:03/07/26
The score is driven primarily by steady underlying profitability and consistent free cash flow, reinforced by constructive (though not flawless) earnings-call signals around cash conversion, leverage improvement, and cost savings. Offsetting these are the recent top-line contraction and balance-sheet leverage constraints, alongside a relatively expensive valuation and mixed technical momentum (negative MACD).
Positive Factors
Recurring service-led business model
A large installed base of route-based, contract customers and subscription-like hygiene rentals gives durable revenue visibility and high retention. This business model supports predictable cash flows, recurring margin conversion and efficient cross-sell, making earnings less cyclical over 2–6 months.
Negative Factors
Elevated leverage constraining flexibility
A materially debt‑dependent capital structure limits headroom for further acquisitions or cyclical shocks. Moderate operating cash flow relative to debt means deleveraging needs sustained FCF and may force tradeoffs between investment, dividends and buybacks over the next 2–6 months if revenue momentum falters.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring service-led business model
A large installed base of route-based, contract customers and subscription-like hygiene rentals gives durable revenue visibility and high retention. This business model supports predictable cash flows, recurring margin conversion and efficient cross-sell, making earnings less cyclical over 2–6 months.
Read all positive factors
Rentokil Initial Key Performance Indicators (KPIs)
Any
Revenue at Constant Rates by Geography
Analyzes revenue across different regions while adjusting for currency fluctuations, highlighting stable growth areas and potential vulnerabilities in diverse markets.
Analyzes revenue across different regions while adjusting for currency fluctuations, highlighting stable growth areas and potential vulnerabilities in diverse markets.
Data provided by:
The Fly
The FlyRentokil Initial (RTO) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$14.82B
Dividend Yield2.2%
Average Volume (3M)792.30K
Price to Earnings (P/E)38.0
Beta (1Y)0.66
Revenue Growth-0.33%
EPS Growth20.26%
CountryUS
Employees68,485
SectorIndustrials
Sector Strength72
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)0.99
Shares Outstanding505,207,980
10 Day Avg. Volume681,139
30 Day Avg. Volume792,301
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)2.71
Price to Sales (P/S)2.15
P/FCF Ratio19.32
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue1.72
Enterprise Value/Gross Profit12.58
Enterprise Value/Ebitda8.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.44
Revenue Forecast (FY)$7.27B
Rentokil Initial Business Overview & Revenue Model
Company Description
Rentokil Initial plc is a global service provider operating across North America, the United Kingdom, Europe, Asia, and the Pacific, delivering a wide array of essential business support solutions through a route-based model. The company offers co...
How the Company Makes Money
Rentokil Initial primarily makes money by selling recurring, service-led contracts and related products across two main activities: (1) Pest Control: The company earns revenue from ongoing pest management programs (typically contract-based) that i...
Rentokil Initial Earnings Call Summary
Earnings Call Date:Mar 05, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Positive
The call balanced clear evidence of operational recovery, solid financial and cash generation, improved margins and decisive strategic moves in North America, international markets and technology adoption against notable legacy and transformation-related costs. The largest negative item is the material increase in the termite provision and associated cash outflows and elevated one-off transformation costs. On balance, the advances in revenue, profit, cash flow, improved lead flow, and tangible efficiency delivery materially outweigh the negatives, though execution and litigation risks remain.Positive Updates
Group Revenue and Profit Growth
Group revenue increased 3.8% to $6.9 billion with organic revenue growth of 2.6%. Adjusted operating profit rose 5.4% to just over $1.0 billion, delivering an adjusted operating profit margin of 15.5% (up 30 basis points). Adjusted basic EPS increased 2.4% to $0.2591.
Negative Updates
Significant Increase in Termite Provision and Litigation Costs
The termite provision increased by $201 million across 2025 (including $122 million in H2). Cash settlements were $95 million in 2025 and management expects similar cash costs in 2026. The long-term inflation assumption for the provision was raised from 2% to 3.2%, reflecting higher legal defense, housing and materials costs.
Read all updates
Q4-2025 Updates
Positive
Negative
Group Revenue and Profit Growth
Group revenue increased 3.8% to $6.9 billion with organic revenue growth of 2.6%. Adjusted operating profit rose 5.4% to just over $1.0 billion, delivering an adjusted operating profit margin of 15.5% (up 30 basis points). Adjusted basic EPS increased 2.4% to $0.2591.
Read all positive updates
Company Guidance
Guidance focused on North America and cash/efficiency: the group plans to expand its multi‑brand strategy to ~30 regional/local brands (from 9), grow its small “satellite” branches from ~150 to ~220 (adding ~70 in 2026) and a total branch network of ~800 by end‑2026; it delivered $25m of in‑year savings in 2025 and is targeting $100m of cost reductions by 2027 while funding growth, expects gross CapEx to remain ~ $196m in 2026, targets free cash flow conversion >80% (2025 was 98% with FCF $615m), plans ~ $200m of bolt‑on M&A in 2026 (reinvested $121m in 2025), expects similar termite cash payments of ~ $95m and one‑off/transformation cash outflows of ~$80–85m in 2026, aims to reduce net debt/EBITDA toward a 2.0–2.5x range (2.6x at year‑end, net debt $3.65bn), and is targeting North America margins of around 20% next year and above 20% by 2027, with management expressing confidence in delivering 2026 results in line with market expectations.Rentokil Initial Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
56
Neutral
Cash Flow
64
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.91B | 5.44B | 5.38B | 3.71B | 2.95B |
| Gross Profit | 2.27B | 726.00M | 4.45B | 3.01B | 728.72M |
| EBITDA | 1.51B | 990.00M | 1.16B | 748.00M | 580.00M |
| Net Income | 470.44M | 307.00M | 381.00M | 232.00M | 263.00M |
Balance Sheet | |||||
| Total Assets | 14.41B | 10.55B | 11.13B | 11.92B | 4.32B |
| Cash, Cash Equivalents and Short-Term Investments | 2.32B | 927.00M | 1.55B | 2.17B | 670.00M |
| Total Debt | 6.12B | 4.14B | 4.73B | 5.40B | 1.97B |
| Total Liabilities | 8.93B | 6.33B | 7.04B | 7.82B | 3.06B |
| Stockholders Equity | 5.49B | 4.23B | 4.09B | 4.10B | 1.26B |
Cash Flow | |||||
| Free Cash Flow | 769.72M | 507.00M | 526.00M | 414.00M | 407.20M |
| Operating Cash Flow | 977.92M | 678.00M | 737.00M | 604.00M | 567.10M |
| Investing Cash Flow | 21.02M | -373.00M | -416.00M | -1.20B | -441.00M |
| Financing Cash Flow | 27.03M | -752.00M | -361.00M | 1.32B | -417.10M |
Rentokil Initial Technical Analysis
Negative
32.76
Price Trends
30.80
Negative
31.33
Negative
29.90
Negative
Market Momentum
-0.18
Negative
47.47
Neutral
72.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RTO, the sentiment is Negative. The current price of 32.76 is above the 20-day moving average (MA) of 29.47, above the 50-day MA of 30.80, and above the 200-day MA of 29.90, indicating a neutral trend. The MACD of -0.18 indicates Negative momentum. The RSI at 47.47 is Neutral, neither overbought nor oversold. The STOCH value of 72.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RTO.
Rentokil Initial Risk Analysis
Rentokil Initial disclosed 27 risk factors in its most recent earnings report. Rentokil Initial reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Rentokil Initial Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $2.03B | 14.91 | 8.32% | ― | 28.34% | 67.93% | |
67 Neutral | $2.61B | 17.11 | 8.94% | 2.20% | 6.53% | 107.41% | |
67 Neutral | $4.72B | 41.09 | 6.24% | 0.71% | 1.41% | -22.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $426.92M | -23.60 | -3.42% | ― | -3.31% | -73.22% | |
60 Neutral | $14.82B | 37.96 | 6.51% | 2.20% | -0.33% | 20.26% | |
60 Neutral | $1.33B | -263.00 | 2.62% | ― | -0.02% | -154.82% |
* Industrials Sector Average
RTO
Rentokil Initial
29.64
6.92
30.45%
ABM
ABM Industries
44.60
-3.60
-7.48%
ACTG
Acacia Research
4.42
0.65
17.24%
CBZ
CBIZ
37.79
-35.02
-48.10%
UNF
UniFirst
271.78
94.89
53.64%
BV
BrightView Holdings
14.30
-1.45
-9.21%
Rentokil Initial Corporate Events
Rentokil Initial Discloses BlackRock Lifting Stake to 13%
Apr 21, 2026
On 17 April 2026, asset manager BlackRock Inc. increased its holding in Rentokil Initial to a total of 13.0% of voting rights, combining 10.44% held through shares and 2.56% via financial instruments, equivalent to 328,889,348 voting rights. The m...
Rentokil Initial Discloses Rise in BlackRock Stake to 12.51%
Mar 30, 2026
On 26 March 2026, investment manager BlackRock, Inc. increased its stake in Rentokil Initial plc, triggering a disclosure of major holdings to the UK market regulator. The position, notified to the company on 27 March, shows BlackRock now controls...
Rentokil Initial Files 2025 Annual Report and Sets 2026 AGM for May
Mar 25, 2026
Rentokil Initial on 25 March 2026 filed its Annual Report and Financial Statements for the year ended 31 December 2025 with the UK Financial Conduct Authority and made the report, the 2026 AGM notice and proxy form available via the National Stora...
Rentokil Initial Files Form 6-K to Lodge 2025 Annual Report with U.S. SEC
Mar 25, 2026
Rentokil Initial plc has filed a Form 6-K with the U.S. Securities and Exchange Commission for March 2026, formally notifying investors that its Annual Report 2025 is now available as an exhibit to the submission. The filing, signed on 25 March 20...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.